A Phase III Randomized Controlled Trial of Secondary Surgical Cytoreduction (SSC) Followed by Platinum-Based Combination Chemotherapy (PBC), with or Without Bevacizumab (B) in Platinum-Sensitive, Recurrent Ovarian Cancer (PSOC): A NRG Oncology/Gynecologic Oncology Group (GOG) Study.